Rituximab and Ocrelizumab in Serum With Multiple Sclerosis

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2022
This article has no abstract
Epistemonikos ID: 8dbb81b298f29253e14ea59940f535b267cf79aa
First added on: Apr 17, 2025